These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 20942912)
1. Gadd45β expression in chondrosarcoma: a pilot study for diagnostic and biological implications in histological grading. Zenmyo M; Tanimoto A; Sakakima H; Yokouchi M; Nagano S; Yamamoto T; Ishido Y; Komiya S; Ijiri K Diagn Pathol; 2010 Oct; 5():69. PubMed ID: 20942912 [TBL] [Abstract][Full Text] [Related]
2. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation. Sangoi AR; Dulai MS; Beck AH; Brat DJ; Vogel H Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275 [TBL] [Abstract][Full Text] [Related]
3. IMP3, CDK4, MDM2 and β-catenin expression in Enchondroma and Central Chondrosarcoma: Diagnostic and prognostic utility. Losada DM; Etchebehere M; Cintra FF; Amstalden EMI Clinics (Sao Paulo); 2024; 79():100483. PubMed ID: 39368400 [TBL] [Abstract][Full Text] [Related]
5. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors. Eefting D; Schrage YM; Geirnaerdt MJ; Le Cessie S; Taminiau AH; Bovée JV; Hogendoorn PC; Am J Surg Pathol; 2009 Jan; 33(1):50-7. PubMed ID: 18852676 [TBL] [Abstract][Full Text] [Related]
6. Analysis of angiogenic factors and cyclooxygenase-2 expression in cartilaginous tumors- clinical and histological correlation. Cintra FF; Etchebehere M; Gonçalves JC; Cassone AE; Amstalden EM Clinics (Sao Paulo); 2011; 66(9):1591-6. PubMed ID: 22179165 [TBL] [Abstract][Full Text] [Related]
7. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone. Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439 [TBL] [Abstract][Full Text] [Related]
8. Genomic Profiling of Low-grade Intramedullary Cartilage Tumors Can Distinguish Enchondroma From Chondrosarcoma. Joseph NM; McGill KC; Horvai AE Am J Surg Pathol; 2021 Jun; 45(6):812-819. PubMed ID: 33239505 [TBL] [Abstract][Full Text] [Related]
9. Expression of insulin-like growth factor II mRNA binding protein 3 (IMP3) in enchondroma and chondrosarcoma. Shooshtarizadeh T; Nazeri A; Zare-Mirzaie A; Movahedinia S Pathol Res Pract; 2016 Apr; 212(4):335-9. PubMed ID: 26948096 [TBL] [Abstract][Full Text] [Related]
10. The role of Thallium-201 scintigraphy and Tc-99m pentavalent dimercaptosuccinic acid in diagnosis and grading of chondrosarcoma. Jo O; Schlicht S; Slavin J; Di Bella C; Pang G; Powell G; Spelman T; Choong PF Eur J Radiol; 2020 Apr; 125():108846. PubMed ID: 32062570 [TBL] [Abstract][Full Text] [Related]
11. Expression of connective tissue growth factor in cartilaginous tumors. Shakunaga T; Ozaki T; Ohara N; Asaumi K; Doi T; Nishida K; Kawai A; Nakanishi T; Takigawa M; Inoue H Cancer; 2000 Oct; 89(7):1466-73. PubMed ID: 11013359 [TBL] [Abstract][Full Text] [Related]
12. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors. Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383 [TBL] [Abstract][Full Text] [Related]
13. MR differentiation of low-grade chondrosarcoma from enchondroma. Choi BB; Jee WH; Sunwoo HJ; Cho JH; Kim JY; Chun KA; Hong SJ; Chung HW; Sung MS; Lee YS; Chung YG Clin Imaging; 2013; 37(3):542-7. PubMed ID: 23041161 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma. Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic role of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in patients with enchondroma and low-grade chondrosarcoma. Yapar A; Ulucaköy C; Sezgin EA; Atalay İB; Ekşioğlu MF Jt Dis Relat Surg; 2020; 31(2):286-290. PubMed ID: 32584727 [TBL] [Abstract][Full Text] [Related]
16. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma. Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647 [TBL] [Abstract][Full Text] [Related]
17. Expression of leukemia inhibitory factor by cartilage-forming tumors of bone: an immunohistochemical study. Gouin F; Moreau A; Couillaud S; Guicheux J; Passuti N; Godard A; Heymann D J Orthop Res; 1999 Mar; 17(2):301-5. PubMed ID: 10221849 [TBL] [Abstract][Full Text] [Related]
18. Is Needle Biopsy Clinically Useful in Preoperative Grading of Central Chondrosarcoma of the Pelvis and Long Bones? Roitman PD; Farfalli GL; Ayerza MA; Múscolo DL; Milano FE; Aponte-Tinao LA Clin Orthop Relat Res; 2017 Mar; 475(3):808-814. PubMed ID: 26883651 [TBL] [Abstract][Full Text] [Related]
19. A reproducible and simple grading system for classical chondrosarcomas. Analysis of 35 chondrosarcomas and 16 enchondromas with emphasis on recurrence rate and radiological and clinical data. Welkerling H; Kratz S; Ewerbeck V; Delling G Virchows Arch; 2003 Dec; 443(6):725-33. PubMed ID: 14513378 [TBL] [Abstract][Full Text] [Related]
20. [Histologic grading of chondrosarcoma. A qualitative and quantitative analysis of 74 cases of the Hamburg bone tumor register]. Welkerling H; Werner M; Delling G Pathologe; 1996 Jan; 17(1):18-25. PubMed ID: 8685092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]